公开(公告)号：WO2012177081A9

公开(公告)日：2013-05-16

申请号：PCT/KR2012004957

申请日：2012-06-22

申请人： KOREA RES INST OF BIOSCIENCE ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  OH SEI RYANG ,  KIM JUNG HEE ,  LE XUAN CANH ,  PARK JI WON ,  LEE SANG WOO ,  LEE JOONGKU ,  LEE HYEONG KYU ,  CHOI SANG HO ,  TRAN THE BACH

发明人： AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  OH SEI RYANG ,  KIM JUNG HEE ,  LE XUAN CANH ,  PARK JI WON ,  LEE SANG WOO ,  LEE JOONGKU ,  LEE HYEONG KYU ,  CHOI SANG HO ,  TRAN THE BACH

IPC分类号： A61K36/185 ,  A61P17/00 ,  A61P29/00

CPC分类号： A61K36/185

摘要： The present invention relates to a composition for preventing and treating inflammatory disease containing an Ardisia tinctoria (Ardisia tinctoria Pit.) extract or a fraction thereof as an active ingredient. More specifically, it has been confirmed that an Ardisia tinctoria extract or a fraction thereof suppresses the production of nitric oxide which is sharply increased by inflammation induction, and it has been confirmed that the Ardisia tinctoria extract is effective in markedly reducing the amount of PGE2, IL-6 (interleukin-6) and IL-1 beta cytokine in a dose dependent fashion, and that it inhibits the expression of iNOS and the COX2 gene and protein and inhibits nuclear translocation of p65 protein and phosphorylation of signal transducers. Also, it has been confirmed that the Ardisia tinctoria extract and an ethyl acetate fraction are effective in suppressing inflammation in a carrageenan-induced mouse podedema model as well. Consequently, the Ardisia tinctoria extract or fraction can be used to advantage as an active ingredient in compositions for preventing and treating or alleviating inflammatory related diseases, or compositions for topical skin preparations, cosmetic compositions and health foods.

摘要翻译： 本发明涉及用于预防和治疗含有Ardisia tinctoria（Ardisia tinctoria Pit。）提取物或其部分作为活性成分的炎性疾病的组合物。 更具体地说，已经证实，通过炎症诱导，Ardisia tinctoria提取物或其一部分抑制了一氧化氮的产生，并且已经证实，Ardisia tinctoria提取物有效地显着降低PGE2的量， IL-6（白细胞介素-6）和IL-1β细胞因子，并且其抑制iNOS和COX2基因和蛋白质的表达，并抑制p65蛋白的核易位和信号转导子的磷酸化。 此外，已经证实，Arridia tinctoria提取物和乙酸乙酯级分也有效地抑制角叉菜胶诱导的小鼠podedema模型中的炎症。 因此，Ardisia tinctoria提取物或级分可用作预防和治疗或减轻炎性相关疾病的组合物或局部皮肤制剂，化妆品组合物和保健食品的组合物中的活性成分。

公开(公告)号：WO2012077975A3

公开(公告)日：2012-08-23

申请号：PCT/KR2011009429

申请日：2011-12-07

申请人： KOREA RES INST OF BIOSCIENCE ,  LEE HYEONG KYU ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  PARK JI WON ,  OH SEI-RYANG ,  KIM DOO-YOUNG ,  OH IL-CHAN ,  LEE JOONGKU ,  JANG HA YOUNG ,  CHOI SANG HO ,  TAMAYO-CASTILLO GISELLE ,  ROSALES-OVARES KATIA ,  GAMEZ-LOBO RODRIGO

发明人： LEE HYEONG KYU ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  PARK JI WON ,  OH SEI-RYANG ,  KIM DOO-YOUNG ,  OH IL-CHAN ,  LEE JOONGKU ,  JANG HA YOUNG ,  CHOI SANG HO ,  TAMAYO-CASTILLO GISELLE ,  ROSALES-OVARES KATIA ,  GAMEZ-LOBO RODRIGO

IPC分类号： A61K8/97 ,  A61Q19/00 ,  A61Q19/08

CPC分类号： A61K8/97 ,  A61K8/418 ,  A61K2800/522 ,  A61Q19/08

摘要： ?Abstract? The present invention relates to an anti-aging and aging retarding composition which contains velvet apple extracts or fractions thereof as active ingredients. More particularly, the velvet apple extracts of the present invention exhibit DPPH free radical scavenging effects and ABTS free radical scavenging effects in a dose-dependent manner. Particularly, ethyl acetate of velvet apple and butanol fractions thereof exhibit excellent antioxidant effects, and therefore, the velvet apple extracts of the present invention may be valuably used as active ingredients of an anti-aging and aging retarding composition, a pharmaceutical composition and a composition for health food.

摘要翻译： ？抽象？ 本发明涉及含有鹿茸提取物或其部分作为活性成分的抗老化和延缓衰老的组合物。 更具体地说，本发明的鹿茸提取物以剂量依赖性方式表现出DPPH自由基清除作用和ABTS自由基清除作用。 尤其是，鹿茸苹果乙酸乙酯和丁醇部分显示出优异的抗氧化作用，因此，本发明的鹿茸提取物可以有效地用作抗衰老和延缓衰老的组合物，药物组合物和组合物 为健康食品。

公开(公告)号：WO2012030137A2

公开(公告)日：2012-03-08

申请号：PCT/KR2011006403

申请日：2011-08-30

申请人： KOREA RES INST OF BIOSCIENCE ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  OH SEI RYANG ,  KIM JUNG HEE ,  LEE HYEONG KYU ,  PARK JI WON ,  JANG HA YOUNG ,  JOUNG HYOUK ,  LEE MEE-YOUNG ,  SON HWA-YOUNG ,  LEE KYOUNG-YOUL

发明人： AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  OH SEI RYANG ,  KIM JUNG HEE ,  LEE HYEONG KYU ,  PARK JI WON ,  JANG HA YOUNG ,  JOUNG HYOUK ,  LEE MEE-YOUNG ,  SON HWA-YOUNG ,  LEE KYOUNG-YOUL

IPC分类号： A61K36/44 ,  A61P29/00 ,  A61P37/00

CPC分类号： A61K36/44

摘要： The present invention relates to a pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing a Diospyros blancoi A. DC. extract as an active ingredient. More specifically, a Diospyros blancoi A. DC. extract inhibits the generation of NO and PGE2 which rapidly increases due to the induction of inflammation, which suppresses the transfer of NF-?B into a nucleus, thereby inhibiting the expression of iNOS and COX-2 and remarkably reducing the amounts of TNF-a, IL-1ß, IL-4 and IL-13. In addition, the Diospyros blancoi A. DC. extract inhibits eosinophilia in bronchoalveolar lavage fluid in the ovalbumin-induced asthma mouse model and inhibits the secretion of immunoglobulins and chemokines in bronchoalveolar lavage fluid and blood. Therefore, the Diospyros blancoi A. DC. extract can be beneficially used as an active ingredient for compositions used for preventing or treating inflammatory diseases, allergic diseases or asthma.

摘要翻译： 本发明涉及一种用于预防或治疗炎性疾病，过敏性疾病或哮喘的药物组合物，其含有黑扁豆（Diospyros blancoi）A. 提取物作为有效成分。 更具体地说，Di Di属（Diospyros blancoi）A.DC。 提取物抑制因炎症诱导而急剧增加的NO和PGE2的产生，抑制NF-κB向细胞核的转移，从而抑制iNOS和COX-2的表达，并显着降低TNF-α的量 ，IL-1β，IL-4和IL-13。 另外，Diospyros blancoi A. DC。 提取物抑制卵清蛋白诱导的哮喘小鼠模型中的支气管肺泡灌洗液中的嗜酸性粒细胞增多，并抑制支气管肺泡灌洗液和血液中的免疫球蛋白和趋化因子的分泌。 因此，Di A. A. DC。 提取物可以有益地用作用于预防或治疗炎性疾病，过敏性疾病或哮喘的组合物的活性成分。

公开(公告)号：WO2009069979A1

公开(公告)日：2009-06-04

申请号：PCT/KR2008/007068

申请日：2008-11-28

申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ,  LEE, Hyeong Kyu ,  LEE, Ho-Jae ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Sang Ku ,  LEE, Joongku ,  YUN, Chang-Hyun ,  KWON, Ok Kyoung ,  LIM, Hye-Sun

发明人： LEE, Hyeong Kyu ,  LEE, Ho-Jae ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Sang Ku ,  LEE, Joongku ,  YUN, Chang-Hyun ,  KWON, Ok Kyoung ,  LIM, Hye-Sun

IPC分类号： C12N15/63

CPC分类号： C12N15/1086

摘要： The present invention relates to an assay system for quantifying Smad activity using a cell line that expresses a Smad transcriptional activity-dependent reporter gene, and the uses thereof, more particularly, an expression vector comprising i) a DNA fragment having repeating SBEs (Smad Binding Element), ii) a lucif erase gene as a transcription reporter, and iii) a selection marker gene; a transfectant transfected with the expression vector; and a method of screening anti-fibrotic agents, anti-cancer agents, or anti-inflammatory agents using the transfectant.

摘要翻译： 本发明涉及使用表达Smad转录活性依赖性报告基因的细胞系定量Smad活性的测定系统及其用途，更具体地，涉及包含i）具有重复SBE（Smad Binding 元素），ii）作为转录报告基因的清除基因，和iii）选择标记基因; 用表达载体转染的转染子; 以及使用该转染子筛选抗纤维化剂，抗癌剂或抗炎剂的方法。

公开(公告)号：WO2007011148A1

公开(公告)日：2007-01-25

申请号：PCT/KR2006/002807

申请日：2006-07-18

申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ,  LEE, Hyeong Kyu ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Joong Ku ,  LEE, Sang Ku ,  KIM, Jung Hee ,  KIM, Doo Young ,  QUAN, Gui Hua ,  KWON, Ok Kyoung ,  KIM, Eun Ah ,  CHOI, Soon Ja ,  SHEN, Guang Hai ,  KIM, Mi Jin ,  PARK, Bo Young ,  MIN, Byung Sun ,  HAN, Gyoon Hee ,  PARK, Hea Young ,  KIM, Gun Cheol ,  KIM, Joo Heon ,  KIM, So Young

发明人： LEE, Hyeong Kyu ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Joong Ku ,  LEE, Sang Ku ,  KIM, Jung Hee ,  KIM, Doo Young ,  QUAN, Gui Hua ,  KWON, Ok Kyoung ,  KIM, Eun Ah ,  CHOI, Soon Ja ,  SHEN, Guang Hai ,  KIM, Mi Jin ,  PARK, Bo Young ,  MIN, Byung Sun ,  HAN, Gyoon Hee ,  PARK, Hea Young ,  KIM, Gun Cheol ,  KIM, Joo Heon ,  KIM, So Young

IPC分类号： A61K36/185 ,  A23L1/29

CPC分类号： A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A23V2200/304

摘要： The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC 4 release in vitro test and the suppressive effect on the IgE level and the cytokine(IL-4, IL-5 and IL- 13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

摘要翻译： 本发明涉及一种组合物，其中含有天竺葵提取物和从其中分离出的具有抗炎，抗过敏和抗哮喘活性的天竺葵酸。 提取物中的天竺葵提取物和从其中分离的叶酸显示出对体外试验中的LTC4S释放的抑制作用以及对IgE水平和细胞因子（IL-4，IL-5和 IL-13）产生，气道高反应性和白细胞浸润在OVA诱导的哮喘小鼠。 因此，它可以用作用于治疗和预防炎性，过敏性和哮喘性疾病的治疗剂或功能性保健食品。

公开(公告)号：WO2006129964A1

公开(公告)日：2006-12-07

申请号：PCT/KR2006/002092

申请日：2006-05-30

申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ,  QUAN, Gui Hua ,  LEE, Hyeong Kyu ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Sang Ku ,  LEE, Joong Ku ,  KWON, Ok Kyoung ,  KIM, Doo Young ,  JOUNG, Hyouk ,  KIM, Mi Jin ,  PARK, Bo Young

发明人： QUAN, Gui Hua ,  LEE, Hyeong Kyu ,  OH, Sei Ryang ,  AHN, Kyung Seop ,  LEE, Sang Ku ,  LEE, Joong Ku ,  KWON, Ok Kyoung ,  KIM, Doo Young ,  JOUNG, Hyouk ,  KIM, Mi Jin ,  PARK, Bo Young

IPC分类号： A61K31/352 ,  A61K36/80

CPC分类号： A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A61K31/35 ,  A61K31/352 ,  A61K36/68 ,  A61K36/80 ,  C07H17/04 ,  A23V2250/21 ,  A23V2200/324 ,  A23V2200/304

摘要： The present invention relates to a composition comprising an extract of Pseudolysimachion genus plant, and the catalpol derivatives isolated therefrom having anti-inflammatory, antiallergic and anti-asthmatic activity. The extractof Pseudolysimachion genus plantand the catalpol derivatives isolated therefrom shows potent suppressing effect on elevated IgE, IL-4 and IL- 13 levels and eosinophilia in the plasma and BALF, and mucus overproduction in the lung tissues in an OVA-induced asthmatic mouse model. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

摘要翻译： 本发明涉及包含假单胞菌属植物提取物和从其分离的具有抗炎，抗过敏和抗哮喘活性的梓醇衍生物的组合物。 假单胞菌属植物提取物和从其中分离的梓醇衍生物显示出对OVA诱导的哮喘小鼠模型中肺组织中升高的IgE，IL-4和IL-13水平以及血浆和BALF中的嗜酸性粒细胞增多和粘液过度产生的有效抑制作用。 因此，它可以用作治疗和预防炎性，过敏性和哮喘性疾病的治疗剂或功能性保健食品。

公开(公告)号：WO2012077976A3

公开(公告)日：2012-09-07

申请号：PCT/KR2011009430

申请日：2011-12-07

申请人： KOREA RES INST OF BIOSCIENCE ,  OH SEI RYANG ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  PARK JI WON ,  LEE HYEONG KYU ,  JOUNG HYOUK

发明人： OH SEI RYANG ,  AHN KYUNG SEOP ,  KWON OK-KYOUNG ,  PARK JI WON ,  LEE HYEONG KYU ,  JOUNG HYOUK

IPC分类号： A61K8/97 ,  A61Q19/00 ,  A61Q19/08

CPC分类号： A61K8/97 ,  A61K2800/522 ,  A61Q19/08

摘要： The present invention relates to an anti-aging composition containingan Elaeocarpus petiolatus extract or a fraction thereof as active ingredients, and more specifically an Elaeocarpus petiolatus extract or a fraction thereof of the invention exhibits a DPPH free radical removal effect and an ABTS free radical removal effect in a concentration-dependent manner in addition to a remarkable superoxide radical removal effect, thereby ensuring an excellent anti-oxidation effect. Therefore, the Elaeocarpus petiolatus extract or the fraction thereof is useful as active ingredients for anti-aging cosmetic compositions, pharmaceutical compositions, and health foods

摘要翻译： 本发明涉及一种抗衰老组合物，其中含有作为活性成分的叶绿素提取物或其部分，更具体地说，本发明的叶柄草提取物或其部分显示出DPPH自由基去除效果和ABTS自由基去除效果 除了显着的超氧自由基去除效果之外，还以浓度依赖性方式，从而确保优异的抗氧化效果。 因此，叶柄草提取物或其部分可用作抗衰老化妆品组合物，药物组合物和保健食品的活性成分

公开(公告)号：WO2012026771A3

公开(公告)日：2012-07-05

申请号：PCT/KR2011006291

申请日：2011-08-25

申请人： KOREA RES INST OF BIOSCIENCE ,  OH SEI RYANG ,  AHN KYUNG SEOP ,  LEE HYEONG KYU ,  KWON OK-KYOUNG ,  JOUNG HYOUK ,  KIM JUNG HEE ,  PARK JI WON ,  LEE JOONGKU

发明人： OH SEI RYANG ,  AHN KYUNG SEOP ,  LEE HYEONG KYU ,  KWON OK-KYOUNG ,  JOUNG HYOUK ,  KIM JUNG HEE ,  PARK JI WON ,  LEE JOONGKU

IPC分类号： A61K36/185 ,  A61P11/06 ,  A61P29/00

CPC分类号： A61K36/185 ,  A61K2236/39

摘要： The present invention relates to a composition comprising Wercklea insignis extracts and fractions thereof for preventing and treating inflammatory diseases or asthma. The Wercklea insignis extracts and fractions thereof according to the present invention inhibit the generation of NO and PGE2 TNF-a which are rapidly increased by the artificial induction of inflammation in macrophages, inhibit the expression of iNOS and COX-2, inhibit MAPK protein phosphorylation, inhibit the nuclear transfer of NF-? ?, and reduce the quantities of cytokines IL-6 and IL-1beta, thereby inhibiting inflammation, inhibiting podedema in a carrageenan-induced mouse model, and significantly reducing the quantities of Th2-type cytokines IL-4 and IL-13 which increase in asthma or allergy. Therefore, the Wercklea insignis extracts and fractions thereof according to the present invention may be valuably used in a composition which is intended for medicine or health-promoting foods and which may require the Wercklea insignis extracts and fractions thereof as active ingredients for preventing and treating inflammatory diseases, allergies, and asthma.

摘要翻译： 本发明涉及包含Wercklea insignis提取物及其级分的用于预防和治疗炎性疾病或哮喘的组合物。 根据本发明的Wercklea insignis提取物及其级分抑制巨噬细胞人工诱导炎症迅速增加的NO和PGE2 TNF-α的产生，抑制iNOS和COX-2的表达，抑制MAPK蛋白磷酸化， 抑制NF-的核转移？ β，并减少细胞因子IL-6和IL-1β的量，从而抑制炎症，抑制角叉菜胶诱导的小鼠模型中的水肿，并显着减少增加的Th2型细胞因子IL-4和IL-13的量 哮喘或过敏。 因此，根据本发明的Wercklea insignis提取物及其级分可以有价值地用于旨在用于医药或健康促进食品的组合物中，并且可能需要Wercklea insignis提取物及其部分作为预防和治疗炎症的活性成分 疾病，过敏和哮喘。

公开(公告)号：WO2008147005A1

公开(公告)日：2008-12-04

申请号：PCT/KR2007/006169

申请日：2007-11-30

申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY ,  LEE, Hyeong-Kyu ,  OH, Sei-Ryang ,  AHN, Kyungseop ,  LEE, Joongku ,  LEE, Sangku ,  LEE, Ho-Jae ,  KIM, Doo-Young ,  KIM, Jung-Hee ,  KIM, Eun-Ah ,  CHOI, Soon-Ja ,  KIM, Soo Hyun ,  LEE, Jung Weon ,  CHOI, Su-Yong

发明人： LEE, Hyeong-Kyu ,  OH, Sei-Ryang ,  AHN, Kyungseop ,  LEE, Joongku ,  LEE, Sangku ,  LEE, Ho-Jae ,  KIM, Doo-Young ,  KIM, Jung-Hee ,  KIM, Eun-Ah ,  CHOI, Soon-Ja ,  KIM, Soo Hyun ,  LEE, Jung Weon ,  CHOI, Su-Yong

IPC分类号： A61K36/185 ,  A23L1/29 ,  A61P35/00

CPC分类号： A61K36/185 ,  A23L33/105

摘要： The present invention relates to an anoikis-inducing agent comprising a Tiarella polyphylla extract, a tiarellic acid compound isolated therefrom or a pharmaceutically acceptable salt thereof, which is specific to cancer cells expressing a tumor-associated antigen L6 or a homolog thereof. The Tiarella polyphylla extract, the tiarellic acid compound isolated therefrom or pharmaceutically acceptable salt thereof of the present invention leads to loss of cell adhesion to reduce cancer cell proliferation and exhibits the effect of inducing cell death in cancer cells expressing a tumor-associated antigen L6 or a homolog thereof, thereby being used for preventing and treating cancer diseases due to a tumor-associated antigen Lβ or a homolog thereof.

摘要翻译： 本发明涉及一种脱氧诱导剂，其包含与其分离的天竺葵多酚提取物，从其分离的噻托溴酸化合物或其药学上可接受的盐，其对表达肿瘤相关抗原L6的癌细胞或其同源物是特异性的。 本发明的天竺葵多酚提取物，从其分离的噻托溴酸化合物或其药学上可接受的盐导致细胞粘附丧失，以减少癌细胞增殖，并表现出在表达肿瘤相关抗原L6的癌细胞中诱导细胞死亡的作用 其同系物，因此用于预防和治疗由于肿瘤相关抗原Lβ或其同源物引起的癌症疾病。

公开(公告)号：WO2007011148A8

公开(公告)日：2007-04-05

申请号：PCT/KR2006002807

申请日：2006-07-18

申请人： KOREA RES INST OF BIOSCIENCE ,  LEE HYEONG KYU ,  OH SEI RYANG ,  AHN KYUNG SEOP ,  LEE JOONG KU ,  LEE SANG KU ,  KIM JUNG HEE ,  KIM DOO YOUNG ,  QUAN GUI HUA ,  KWON OK KYOUNG ,  KIM EUN AH ,  CHOI SOON JA ,  SHEN GUANG HAI ,  KIM MI JIN ,  PARK BO YOUNG ,  MIN BYUNG SUN ,  HAN GYOON HEE ,  PARK HEA YOUNG ,  KIM GUN CHEOL ,  KIM JOO HEON ,  KIM SO YOUNG

发明人： LEE HYEONG KYU ,  OH SEI RYANG ,  AHN KYUNG SEOP ,  LEE JOONG KU ,  LEE SANG KU ,  KIM JUNG HEE ,  KIM DOO YOUNG ,  QUAN GUI HUA ,  KWON OK KYOUNG ,  KIM EUN AH ,  CHOI SOON JA ,  SHEN GUANG HAI ,  KIM MI JIN ,  PARK BO YOUNG ,  MIN BYUNG SUN ,  HAN GYOON HEE ,  PARK HEA YOUNG ,  KIM GUN CHEOL ,  KIM JOO HEON ,  KIM SO YOUNG

IPC分类号： A61K36/185 ,  A23L33/00

CPC分类号： A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A23V2200/304

摘要： The present invention relates to a composition comprising an extract of Tiarella polyphylla, and tiarellic acid isolated therefrom having anti-inflammatory, anti-allergic and anti-asthmatic activity. The extract of Tiarella polyphylla and the tiarellic acid isolated therefrom shows the inhibitory effect on the LTC 4 release in vitro test and the suppressive effect on the IgE level and the cytokine(IL-4, IL-5 and IL- 13) production, airway hyperresponsiveness, and leukocyte infiltration in OVA-induced asthmatic mice. Therefore, it can be used as the therapeutics or functional health food for treating and preventing inflammatory, allergic and asthmatic disease.

摘要翻译： 本发明涉及一种组合物，该组合物包含提拉曲霉（Tiarella polyphylla）提取物和从其中分离的具有抗炎，抗过敏和抗哮喘活性的亚苄基（tiarellic acid）。 Tiarella polyphylla的提取物和从其分离的Tiarellic acid显示出对体外LTC 4 /释放试验的抑制作用和对IgE水平和细胞因子（IL-4，IL-5和IL-5）的抑制作用 IL-13）产生，气道高反应性以及OVA诱导的哮喘小鼠中的白细胞浸润。 因此，它可以用作治疗和预防炎症，过敏和哮喘疾病的治疗剂或功能性保健食品。